Depomed Prevails Against Actavis In Gralise Case
August 19, 2014 at 11:14 AM EDT
Shares of Depomed (NASDAQ: DEPO) are trading sharply higher following news of a favorable court ruling versus competitor Actavis ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.